Americans Seek Affordable IVF in Greece
Analysis based on 12 articles · First reported Aug 22, 2026 · Last updated Aug 31, 2026
The rising trend of Americans seeking IVF abroad may pressure U.S. fertility clinics to lower prices and improve transparency, potentially affecting their revenue and market share. Increased medical tourism could boost Greece's healthcare and tourism sectors, while U.S. pharmaceutical companies may see reduced demand for IVF medications as patients purchase them abroad.
A growing number of Americans are traveling to Greece and Spain for in vitro fertilization (IVF) treatment due to the high cost of fertility care in the United States. The average cost of a single IVF cycle in the U.S. exceeds $29,000, often not covered by insurance, while similar treatment in Greece costs between $3,000 and $6,000. The trend is driven by affordability, shorter wait times, and the opportunity to combine treatment with vacation. President Donald Trump's administration has proposed rules to expand employer coverage and launched TrumpRx to reduce medication costs, but these measures have not yet significantly lowered overall expenses. The number of Americans seeking European clinics grew by over 37% last year, according to the European Fertility Society. Clinics like Pelargos IVF Medical Group and Serum IVF in Greece cater to international patients, while U.S. providers like CNY Fertility offer lower-cost alternatives domestically. However, medical tourism for IVF carries risks, including regulatory differences, language barriers, and challenges in transferring records and medications.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard